Alyssa Walker, PharmD, BCPS, BCIDP
Walker is an infectious diseases medical science liaison for bioMérieux. As an infectious diseases pharmacist with more than 10 years of clinical experience, she understands the complexities of managing and measuring an AMS program and the need for responsible applications of diagnostic technologies.
Articles
Antibiotic De-Escalation: Is This the Right Outcome Measure?
November 16th 2023The proposed clinical benefits of de-escalation has contributed to its lukewarm adoption in some settings. This article looks at the challenges in measuring the impact of de-escalation, and the ongoing search for more meaningful metrics to evaluate the success of antimicrobial stewardship (AMS) programs.
Read More
Latest Updated Articles
Published: August 27th 2024 | Updated: August 28th 2024
Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties
Published: December 23rd 2024 | Updated: December 26th 2024
Ceftolozane Tazobactam Linked to Increased Clinical Success in Pneumonia
Published: December 23rd 2024 | Updated: December 26th 2024
From Pathogen to Infectious Disease Diagnosis: Identifying a Novel Variant of Klebsiella Pneumoniae
Published: December 24th 2024 | Updated: December 26th 2024
COVID-19 Roundtable: Prophylaxis for the Immunocompromised
Published: December 12th 2024 | Updated: December 26th 2024
COVID-19 Therapy Roundtable: Addressing Inpatient Clinical Care
Published: December 20th 2024 | Updated: December 26th 2024
CACTUS Study Compares Ceftolozane-Tazobactam vs. Ceftazidime-Avibactam for MDR Pseudomonas
